Busy. Please wait.

show password
Forgot Password?

Don't have an account?  Sign up 

Username is available taken
show password


Make sure to remember your password. If you forget it there is no way for StudyStack to send you a reset link. You would need to create a new account.

By signing up, I agree to StudyStack's Terms of Service and Privacy Policy.

Already a StudyStack user? Log In

Reset Password
Enter the associated with your account, and we'll email you a link to reset your password.

Remove ads
Don't know
remaining cards
To flip the current card, click it or press the Spacebar key.  To move the current card to one of the three colored boxes, click on the box.  You may also press the UP ARROW key to move the card to the "Know" box, the DOWN ARROW key to move the card to the "Don't know" box, or the RIGHT ARROW key to move the card to the Remaining box.  You may also click on the card displayed in any of the three boxes to bring that card back to the center.

Pass complete!

"Know" box contains:
Time elapsed:
restart all cards

Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.

  Normal Size     Small Size show me how

Sesion 2 pharm3

Pharm -3- Pharmacodynamics

What is Pharmacology the study of the interaction of chemicals with biological systems
What is Pharmacodynamics the study of the biochemical and physiological effects of drugs and their mechanism of action.
What is Pharmacokinetics ADME, absorption, distribution, metabolism, exrection
Objectives of pharmacodynamics 1. to show the chemical or physical interactions between a drug and a target cell 2. the sequence and scope of actions of each drug 3. to provide the basis for both the therapeutic use of a drug and the design of new and superior drugs
What is a Drug chemical substance that alters physiologic function of cells and tissues through a chemical reaction Chemical substances used to prevent, treat or provide symptomatic relief of disease
What are the 5 Basic Principles of Drug Theory 1 binds specifically 2 alter pathways 3 inhibit/activate 4 compare to basal levels 5 proportional response
Drugs chemically bind to specific cellular macromolecules known as receptors ultimately triggering some biochemical response. The response can be measured at the level of the cell, tissue, organ or whole organism refers to what part of the drug theory 1 binds specifically
II. Drugs do not create new cellular responses but alter preexisting ones refers to what part of drug theory 2 alter pathways
III. Drugs inhibit or activate biochemical or physiological processes or replace elements needed to initiate or enhance cellular processes refers to what part of drug theory 3 inhibit/activate
IV. The response to and effectiveness of a specific drug must be measured by comparing it to the physiologic activity of the system it affects prior to administration refers to what part of drug theory 4 compare to basal levels
V. The response of a system to any given drug is proportional to the dose of the drug, the extent of the physical interaction with its receptors and the number of receptors containing bound drug refers to what part of drug theory 5 proportional response
Most drugs are what size MW between 100 and 1000 g/mole
a sufficient size gives a compound a unique structure which facilitates what selective receptor binding
smaller compounds and ions do not _____ ____ to receptors Bind selectively
Why do large drug molecules need to be administered parentally may not readily be absorbed in the GI tract (protein drugs)
The hypothesis that drugs must have a complementary shape to the receptor for binding to occur is called Lock and Key Hypothesis
Stereo isomerism is important because Normally only one optical isomer of a drug is pharmacologically active
Drug Polarity refers to it being either __________ or __________ Hydrophobic or Hydrophilic
Site of Drug Action are known as what and give 3 sites of drug action receptor 1 Membrane protein (adrenergic receptor) 2 Cytoplasmic/extracellular enzyme (gastric proton pump, cyclooxygenase (COX) 3 Nucleic acid (alkylating agents)
What are the 2 Main categories for receptors Molecules essential to normal cellular function (enzymes, nucleic acid, etc.) and **Molecules specifically involved in intercellular communication (specialized receptors)
**Molecules specifically involved in intercellular communication (specialized receptors) are more commonly known as what Generally are G protein linked receptors
What are the Common Features of Receptors Molecular Weight 45 to 200 kilodaltons, may be composed of a single or multiple protein subunits, Receptor activities are localized to a discrete portion of the receptor
How are receptors Grouped Super families, Families and finally subtypes IE GPCR, Alph or Beta, Alpha1 Alpha 2, Alpha 1a
I. What are the characterisitcs of the 7 Trans membrane spanning (TMS) G Protein Coupled Receptors (Metabotropic Receptors) i. 7, nonpolar, transmembrane regions ii. three extracellular loops iii. three intracellular loops iv. extracellular amino terminal tail v. intracellular carboxy terminal tail vi. coupled to G proteins
Where does the G protein bind to within the GPCR Heterotrimeric G proteins bind to third intracellular loop and carboxy terminal tail
What is the time frame for action with GPCR's Minutes
What ere the 5 Common features of membrane-bound receptor 1 Hydrophobic and hydrophilic segments 2 Act as signal transducers 3 Initiate a signal transduction pathway 4 May have enzymatic properties 5 Often contain lipid or carbohydrate modifications
what type of receptor do 30-50% of drugs affect GPCRs
What two subunits of the G protein never separate gamma and Beta
what subunit separates away from the betas and gamma subunits of the G protein Alpha subunit
alpha stimulatory subtypes cause ____ adenlyle cyclase activity and ______ cAMP Increase adenylyl cyclase activity and Increase cAMP
What are common alpha stimulatory receptors B1 adrenergic, B2 adrenergic, glucagon receptor
Alpha i subunit subtypes cause ____ adenylyl cyclase activity and ______ cAMP Decrease adenylyl cyclase activity and decrease cAMP
What are common alpha i receptors alpha 2 adrenergic receptor, mu opiod receptor
Alpha q/11 subtype _________ phospholipase C which then ________ protein kinase C and IP3 increase phospholipase C and then activates protein kinase C and IP3
In desensitization and internalization of receptors what is the key in determining if it gets sent to lysosome or back to the membrane length of stimulation
In desensitization and internalization what is the molecule that phosphorylates activated receptors that don't have their G-proteins attached anymore GRK (G protein coupled receptor kinase)
What molecule attaches to phosphorylated receptors to signal internalization Beta-arr
decreased effect to a drug when used at a similar dose is know as _______ or _______ desensitization or tachyphylaxis
This typically deals more with the rapid effects of phosphorylation or internalization of receptor and no receptor degredation desensitization or tachyphylaxis
Like desensitization manifests a decreased response but has long lasting effect due to degradation of the receptor. Down-regulation and tolerance
increased response to a drug following increased synthesis of receptors sensitization
adaptive response that is a result of receptor blockade (long term treatment with antagonist) Sensitization
Results with loss of endogenous ligand sensitization
long term treatment with antagonist receptor blockade
what are the common alpha q/11 receptor types Alpha 1 adrenergic receptor, angiotensin
these receptors are multiprotein subunits usually tatramer or pentamer and make a pore through wich positively or negatively charged molecules flow ligan gated ion-channels
what is the timeframe of action of ion channel receptors miliseconds
receptors that produce an effect by altering cell's membrane potential ion channel receptors
polypeptide receptor that has extracellular hormone binding domain, cytoplasmic enzyme domain, hydrophobic segment that connects the binding domains. tyrosine kinase receptors
what is the time frame of action for tyrosine kinase minutes/hours/days
receptors effects are on cellular function as well as the regulation of the transcription of gene involved in cell growth and differentiation tyrosin-kinase receptor
what are 4 endogenous activators of tyrosin kinase receptors insulin, epidermal growth factor, platelet-derived growth factor, and atrial natriuretic factor.
polypetide receptor with extracellular hormone binding domain hydrophobic segment that connects domains, separate mobile tyrosine kinase JANUS KINASE (JAK) Cytokine receptor
Receptor that regulates genes involved in synthesis and release of many inflammatory mediators and hematopoeitic factors Cytokine receptor
What is the time frame of action of a cytokine receptor hours to days
Endogenous activators of cytokine receptors cytokines, growth hormones, erythropoietin, interferon
hormone binding receptor with DNA binding domain transcription activating domain which primarily acts to regulate gene transcription intracellular receptors
What is the time frame of action of an intracellular receptor hours/days
What are the endogenous activators of intracellular receptors corticosteroids mineralcorticoids sex steroids vitamin D thryoid hormone
Drugs that act at nuclear receptors are hydrophobic
What are the 4 types of bond in decreasing bond strengths covalent bond ionic bond hydrogen bond Van der Waals
measurement of how readily a molecule will bind to a receptor binding affinity Kd
concentration of drug required to bind 1/2 of the receptors in a fixed population Kd binding affinity
The Higher Kd of the drug the _______ its affinity for the receptor the lower its affinity for the receptor high Kd equals low affinity
binding of a drug to a receptor can be reversible or irreversible true or false true
true or false binding of a drug to the receptor is a stereoselective reaction true lock and key theory
True or false specificity of drug to receptor is not absolute and therefore you can get side effects true
L+R <---> LR* -----> biological response law of mass action L=ligand R=receptor R* activated receptor
end result of ligand receptor interactions can be biochemical, physiological or both biologic response- only specific drug-receptor complexes will produce biological response
what is the equation for Kd Kd= [L][R]/[LR]
ability of a ligand to induce the receptor to adopt an active conformation to get a biological response efficacy
Efficacy is measured bewteen what 0-1
substance which bind a receptor and produces a biological response agonist
substance which has a maximum biological response can reach that response be either activating 100% or less of the receptors have an efficacy of 1 full agonist
A substance that produces even at highest concentrations and 100% receptor binding less than maximum response of system efficacy less than 1 partial agonist
substance that produces a decrease in basal activity of a system inverse agonist
compounds that increase the affinity or efficacy of agonists for the receptor and act at a site other than the active site allosteric agonist or enhancers
What is a chemical antagonist and name an example direct chemical interaction between agonist and antagoinist in such a way that renders the agonist pharmacologically inactive such as chelating agents
what is physiological antagonism interaction of two agonists that act independantly but happen to cause opposite effects and cancel each other out. actylcholine and epinepherine's actions on the heart
substance that inhibits a biological response by acting at a site beyond the receptor and can block agonist acting through more than one receptor. indirect antagonism
Most frequently encountered type of agonist encountered in clinical practice agonist and antagonist compete for the binding site on the receptor competitive antagonist has affinity but no efficacy
Types of competitive antagonists reversible antagonist- (equilibrium competitive antagonist) irreversible antagonist- (nonequilibrium competitive antagonist) Allosteric Antagonism
type of competitive antagonist that binds reversibly to receptor antagonist can be overcome by agonist at receptor reverible antagonism
type of competitive antagonist that binds irreversibly via covalent bond to the receptor cannot be overcome by agonist at receptor Irreversible antagonist
Chemical compound that reduces the affinity and or efficacy of agonist for receptors by binding and altering receptors conformation binds to distinct location than agonist binding region allosteric antagonist
Created by: smaxsmith